- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04479059
Endometrial Follicular Fluid Flushing and IVF Outcome
Objective: In this study, our aim will be investigating the pregnancy results in unexplained infertile women undergoing ICSI, by flushing the endometrial cavity with folliculer fluid, that we maintain mature follicules inside them in oocyte retrieval day.
Study Design: 100 subfertile women who applied to Zeynep Kamil Hospital, In Vitro Fertilization Center between October 2016 to May 2017 will be randomized with computer generated programme. The patients will be divided into two groups; follicular fluid group (n=50) and control group (n=50). The inclusion criterias are: age between 20-39 years, basal FSH level < 10 mIU/ml, body mass index<35 kg/m2 and E2 levels in human chorionic gonadotropin (hCG) day between 1000-4000 pg/ml. Patients meets these criteria will be included to the study programme. The exclusion criteria are determined as below: previously diagnosed endometriosis, uterine leiomyomas, hydrosalpinx, endocrinological disorders; previous history of implantation failure in IVF/ICSI cycles and severe male factor infertility.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective: In this study, our aim will be investigating the pregnancy results in unexplained infertile women undergoing ICSI, by flushing the endometrial cavity with folliculer fluid, that we maintain mature follicules inside them in oocyte retrieval day.
Study Design: 100 subfertile women who applied to Zeynep Kamil Hospital, In Vitro Fertilization Center between October 2016 to May 2017 will be randomized with computer generated programme. The patients will be divided into two groups; follicular fluid group (n=50) and control group (n=50). The inclusion criterias are: age between 20-39 years, basal FSH level < 10 mIU/ml, body mass index<35 kg/m2 and E2 levels in human chorionic gonadotropin (hCG) day between 1000-4000 pg/ml. Patients meets these criteria will be included to the study programme. The exclusion criteria are determined as below: previously diagnosed endometriosis, uterine leiomyomas, hydrosalpinx, endocrinological disorders; previous history of implantation failure in IVF/ICSI cycles and severe male factor infertility.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
inclusion criteria:age between 20-39 years, basal FSH level < 10 mIU/ml, body mass index<35 kg/m2 and E2 levels in human chorionic gonadotropin (hCG) day between 1000-4000 pg/ml. -
Exclusion Criteria:previously diagnosed endometriosis, uterine leiomyomas, hydrosalpinx, endocrinological disorders; previous history of implantation failure in IVF/ICSI cycles and severe male factor infertility.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
|
|
Experimental: İntracavitary fluid flushing
|
Follicular fluid obtained during OPU will be used for endometrial cavity flushing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical pregnancy
Time Frame: during last 24 months
|
intrauterine pregnancy with metal cardiac activity
|
during last 24 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ebru Cogendez
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clinical Pregnancy
-
Antalya IVFRecruiting
-
Aretaieion University HospitalCompletedClinical Pregnancy Rate
-
University Hospital, GhentCompletedClinical Pregnancy RateBelgium
-
Antalya IVFTerminated
-
Universitair Ziekenhuis BrusselUnknown
-
The First Affiliated Hospital of Zhengzhou UniversityUnknownOvulation Induction | Clinical Pregnancy RateChina
-
Kaali Institute IVF CenterForgacs Intezet Kft.TerminatedClinical Pregnancy After Single Embryo TransferHungary
-
University of New MexicoNational Center for Research Resources (NCRR)TerminatedPregnancy | Randomized Clinical Trial | Docosahexaenoic AcidUnited States
-
McGill University Health Centre/Research Institute...TerminatedInfertility | Clinical Pregnancy RateCanada
-
The First Affiliated Hospital of Zhengzhou UniversityUnknown
Clinical Trials on follicular fluid flushing
-
Centrum Clinic IVF CenterCompletedDiminished Ovarian Reserve | Invitro Fertilization | OocyteTurkey
-
Royan InstituteCompletedEmbryo Implantation | Follicular Fluid | Granulosa CellIran, Islamic Republic of
-
University Hospital Inselspital, BerneUniversity of BernCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Nawara Mohamed HashishCompletedIntra-cytoplasmic Sperm Injection OutcomeEgypt
-
Imperial College LondonGuy's and St Thomas' NHS Foundation Trust; University Hospital Southampton... and other collaboratorsRecruitingStroke | Neurocognitive Dysfunction | Silent Cerebral Infarction | Vascular Brain InjuryUnited Kingdom
-
Imperial College LondonImperial College Healthcare NHS TrustRecruitingStroke | Aortic Valve Stenosis | Silent Cerebral Infarct | Vascular Brain InjuryUnited Kingdom
-
CHU de Quebec-Universite LavalUnknownInfertility | Unexplained InfertilityCanada